HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Norio Yasui-Furukori Selected Research

bromperidol (Impromen)

4/2007Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia.
4/2002Comparison of prolactin concentrations between haloperidol and bromperidol treatments in schizophrenic patients.
2/2002The characteristics of side-effects of bromperidol in schizophrenic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Norio Yasui-Furukori Research Topics

Disease

49Schizophrenia (Dementia Praecox)
10/2022 - 06/2002
26Major Depressive Disorder (Major Depressive Disorders)
03/2022 - 04/2009
12Hyperprolactinemia
01/2021 - 04/2002
10Epilepsy (Aura)
10/2020 - 05/2007
8Sleep Initiation and Maintenance Disorders (Insomnia)
01/2020 - 06/2011
8Sleepiness
01/2012 - 12/2002
6Mental Disorders (Mental Disorder)
01/2022 - 06/2007
6Body Weight (Weight, Body)
10/2021 - 06/2003
6Bipolar Disorder (Manic Depressive Psychosis)
01/2021 - 01/2013
5Hallucinations (Hallucination)
12/2021 - 08/2009
4Diabetes Mellitus
09/2020 - 01/2016
4Obesity
01/2018 - 06/2014
4Overweight
01/2018 - 01/2013
4Hypertension (High Blood Pressure)
01/2016 - 01/2002
3Mania (Manias)
01/2022 - 11/2020
3Type 2 Diabetes Mellitus (MODY)
09/2020 - 01/2009
3Delirium
11/2018 - 04/2009
3Panic Disorder (Panic Attack)
01/2017 - 01/2012
3Cognitive Dysfunction
01/2015 - 01/2012
3Tremor (Tremors)
01/2012 - 02/2002
2Treatment-Resistant Schizophrenia
10/2022 - 01/2022
2Mood Disorders (Mood Disorder)
01/2022 - 11/2013
2Hyperventilation
01/2022 - 01/2012
2Pain (Aches)
01/2022 - 01/2019
2Brain Diseases (Brain Disorder)
12/2021 - 01/2021
2Neutropenia
12/2020 - 11/2014
2Eosinophilia
12/2020 - 01/2012
2Medically Unexplained Symptoms
12/2019 - 01/2017
2Breast Neoplasms (Breast Cancer)
01/2019 - 11/2010
2Weight Gain
01/2018 - 01/2015
2Seizures (Absence Seizure)
01/2015 - 03/2014
2Intellectual Disability (Idiocy)
01/2015 - 01/2014
2Disease Progression
11/2014 - 01/2002
2Metabolic Bone Diseases (Osteopenia)
08/2014 - 12/2011
2Alzheimer Disease (Alzheimer's Disease)
01/2014 - 05/2004
2Neuroleptic Malignant Syndrome
07/2013 - 02/2003
2Psychomotor Agitation (Akathisia)
01/2012 - 02/2002
2Nausea
01/2012 - 06/2011
2Dizziness (Lightheadedness)
01/2012 - 06/2011

Drug/Important Bio-Agent (IBA)

28Antipsychotic Agents (Antipsychotics)IBA
10/2022 - 03/2006
17Risperidone (Risperdal Consta)FDA LinkGeneric
11/2021 - 06/2002
17Paroxetine (Paxil)FDA LinkGeneric
01/2018 - 04/2011
14Pharmaceutical PreparationsIBA
12/2021 - 02/2002
12Antidepressive Agents (Antidepressants)IBA
01/2022 - 04/2009
10ProlactinIBA
01/2021 - 04/2002
9Aripiprazole (Abilify)FDA Link
11/2021 - 10/2010
8Olanzapine (Zyprexa)FDA Link
11/2021 - 01/2009
7LithiumIBA
12/2020 - 11/2013
6Valproic Acid (Depakote)FDA LinkGeneric
11/2020 - 03/2012
6Dopamine (Intropin)FDA LinkGeneric
09/2013 - 02/2003
5Clozapine (Clozaril)FDA LinkGeneric
10/2022 - 03/2014
5Paliperidone PalmitateFDA Link
11/2021 - 02/2003
5Cytochrome P-450 CYP2D6 (CYP2D6)IBA
10/2021 - 02/2003
5Therapeutic UsesIBA
03/2019 - 10/2011
5Haloperidol (Haldol)FDA LinkGeneric
01/2004 - 01/2002
4Anticonvulsants (Antiepileptic Drugs)IBA
01/2022 - 01/2015
4Carbamazepine (Tegretol)FDA LinkGeneric
11/2020 - 01/2002
4Glucose (Dextrose)FDA LinkGeneric
09/2020 - 01/2009
4quazepam (Doral)FDA Link
12/2003 - 12/2002
3Duloxetine Hydrochloride (Cymbalta)FDA Link
01/2022 - 09/2013
3Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2022 - 04/2009
3Lamotrigine (Lamictal)FDA LinkGeneric
11/2020 - 07/2013
3EscitalopramFDA Link
01/2020 - 01/2015
3Proteins (Proteins, Gene)FDA Link
01/2019 - 11/2010
3Cytochrome P-450 CYP2C19IBA
01/2018 - 01/2005
3superoxide dismutase 2IBA
01/2014 - 03/2012
3Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
06/2012 - 02/2003
3bromperidol (Impromen)IBA
04/2007 - 02/2002
2Biological ProductsIBA
07/2022 - 12/2021
2Biomarkers (Surrogate Marker)IBA
07/2022 - 01/2014
2Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
01/2022 - 01/2020
2Cholinergic Antagonists (Anticholinergics)IBA
01/2022 - 01/2022
2Anti-Anxiety Agents (Anxiolytics)IBA
01/2022 - 09/2021
2Hypnotics and Sedatives (Sedatives)IBA
01/2022 - 09/2021
2Psychotropic Drugs (Psychoactive Drugs)IBA
01/2022 - 01/2021
2perospironeIBA
12/2021 - 04/2009
2Quetiapine Fumarate (Seroquel)FDA Link
09/2021 - 09/2013
2blonanserinIBA
09/2021 - 09/2010
2Testosterone (Sustanon)FDA Link
01/2021 - 08/2014
2Blood Glucose (Blood Sugar)IBA
09/2020 - 01/2019
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2020 - 03/2019
2Adenosine Triphosphate (ATP)IBA
01/2020 - 03/2016
2CholesterolIBA
01/2020 - 03/2016
2SteroidsIBA
01/2020 - 01/2017
2AnionsIBA
01/2019 - 11/2010
2Peptides (Polypeptides)IBA
01/2019 - 11/2010
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2019 - 11/2010
2HDL CholesterolIBA
01/2018 - 01/2013
2EnzymesIBA
01/2016 - 01/2013
2Glutathione Transferase (Glutathione S-Transferase)IBA
01/2016 - 01/2013
2Cytochrome P-450 CYP3AIBA
03/2014 - 01/2002
2Nerve Growth Factors (Neurotrophins)IBA
01/2014 - 04/2011
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2014 - 10/2012
2Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2014 - 01/2014
2Serotonin (5 Hydroxytryptamine)IBA
09/2013 - 09/2010

Therapy/Procedure

8Therapeutics
12/2020 - 04/2009
4Polypharmacy
03/2022 - 01/2020
4Drug Therapy (Chemotherapy)
03/2022 - 01/2014
3Injections
12/2019 - 12/2018
3Renal Dialysis (Hemodialysis)
01/2017 - 01/2016